Program Outline

Program

All conference sessions will be held at the Sofitel Hotel, 25 Collins Street Melbourne in the Arthur Streeton Auditorium.

Wednesday 16 November 2022

Edit

Fitzroy Ballroom Foyer at the Sofitel Hotel Melbourne.

Edit

Being held in the Fitzroy Ballroom at the Sofitel Hotel Melbourne.

Edit

Join your PCC colleagues for a special screening of the Conquering Cancer Documentary at Palace Cinemas Kino.

Thursday 17 November 2022

Edit

Chaired by Dr Claire Nightingale, Melbourne School of Population and Global Health, The University of Melbourne

What does modelling tell us about self-collection and elimination?

Associate Professor Megan Smith 

Daffodil Centre (a joint venture of Cancer Council NSW and The University of Sydney)

Provider/stakeholder views on universal self-collection

Ms Nicole Creagh

The Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne

Self-collection delivery models, provider training and support along the clinical pathway

Dr Karen Bartholomew

Waitemata District Health Board (DHB) and Auckland DHB

Getting the message out: review of what we know about communications for under-screened populations and about self-collection

Ms Kate Broun

Cancer Council Victoria

Panel discussion

Chaired by Professor Marion Saville AM, Australian Centre for Prevention of Cervical Cancer

Edit

Chaired by Professor Bev Lawton, Te Tātai Hauora o Hine (the Centre for Women’s Health Research) at Te Herenga Waka, Victoria University Wellington, Aotearoa New Zealand.

Opportunities for innovation in school-based vaccination: lessons from Yarning About HPV Vaccination

Dr Tamara Butler

The University of Queensland

Innovative and flexible community-based test and treat models: Lessons from STI testing

Professor Rebecca Guy

Kirby Institute, UNSW Sydney

Point of care testing: the PREVENT study

Dr Amie Powell

The University of Notre Dame Australia

Point of care testing: experiences from New Zealand

Ms Anna Adcock

Te Tātai Hauora o Hine National Centre for Women’s Health Research Aotearoa, Te Herenga Waka Victoria University of Wellington, Aotearoa New Zealand

Panel discussion

Chaired by Professor John Kaldor, Kirby Institute, UNSW Sydney

Edit

Chaired by Professor Marion Saville AM, Australian Centre for the Prevention of Cervical Cancer.

How are high-resource settings managing triage of HPV positive women? A review of options used in Australia, England and New Zealand.

Associate Professor Megan Smith

Daffodil Centre (a joint venture of Cancer Council NSW and The University of Sydney)

COMPASS update

Professor Karen Canfell

Daffodil Centre (a joint venture of Cancer Council NSW and The University of Sydney)

Latest evidence on triage of HPV positive women: emerging data on dual-stain

Dr Nico Wentzensen

National Cancer Institute, United States of America

Panel discussion: Key considerations for triaging HPV positive women and the impact of screening history

Edit

Chaired by Professor Julia Brotherton, Australian Centre for the Prevention of Cervical Cancer.

Keynote address

Dr Nono Simelela

The World Health Organization

Evidence supporting one-dose vaccination: outcomes from the one-dose consortium

Professor Deborah Watson-Jones

Mwanza, Tanzania & Clinical Research Department, London School of Hygiene and Tropical Medicine, London

Evidence supporting one-dose HPV vaccination from India

Dr Partha Basu

International Agency for Research on Cancer, France

An update on global vaccine supply and demand

Ms Tania Cernuschi

The World Health Organization

NCIRS update on vaccination in the region

Professor Kristine Macartney

National Centre for Immunisation Research and Surveillance

The one dose debate 

Edit

Being held at the Melbourne Museum. A ticket to the dinner is included in all in-person registrations.

Friday 18 November 2022

Edit

Chaired by Professor Woo Yin Ling, University of Malaya

How are we tracking on the pathway to elimination in our region?

Ms Hawa Camara

Kirby Institute, UNSW Sydney

Update from the SUCCESS project: Scale Up Cervical Cancer Elimination with Secondary prevention Strategy

Ms Azadeh Baghaki

The World Health Organization

Implementing the WHO guidelines: factors to consider for WLHIV and other high-risk groups, like rural populations

The World Health Organization

An initiative to eliminate cervical cancer in the Western Pacific: A partnership between Minderoo and C4

TBC

Edit

Chaired by Professor Andrew Vallely, Kirby Institute, UNSW Sydney.

The impact and cost-effectiveness of point-of-care primary HPV testing in Papua New Guinea and other Pacific Islands

Dr Diep Nguyen

Daffodil Centre (a joint venture of Cancer Council NSW and The University of Sydney)

Scaling-up HPV testing and treatment in Tuvalu

Dr Virisila Sema
Ministry of Health, Tuvalu
and
Associate Professor Deborah Bateson
Family Planning NSW

Treatment for precancer: considerations in using ablation or excision

Professor Woo Yin Ling

University of Malaya

 

Panel discussion: Tailoring delivery models to your setting – from point-of-care to batch HPV testing and treatment options

Edit

Detailed agenda for this session coming soon.

Edit

Chaired by Dr Dorothy Machalek, Kirby Institute, UNSW Sydney.

Edit

Chaired by Dr Sharon Hanley, Hokkaido University, Japan.

COVID-19 and Cancer Global Modelling Consortium

TBC

The COVID-19 and Cancer Observatory: estimates of additional deaths that would occur due to covid delays 

Dr Adam Keane

Daffodil Centre (a joint venture of Cancer Council NSW and The University of Sydney)

UNICEF update on vaccination programs that weathered the pandemic

TBC

How Bangladesh continued screening during COVID-19 outbreaks

TBC

AVE as a triage for HPV positive women: updated data and impact of COVID on this work

Dr Kanan Desai

National Cancer Institute, United States of America

Panel discussion: How can countries implement cervical cancer elimination plans during the COVID-19 pandemic?

Program subject to change without notice. Timings to be used as a guide only.